Rivastigmine 4.6mg
You Searched
₹65


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
In Alzheimer's disease : In people with Alzheimer�s disease, certain nerve cells die in the brain. This results in lower levels of a chemical called acetylcholine which helps nerve cells to communicate with each other. This leads to symptoms of dementia such as memory loss, confusion, disorientation, problems with speech and language, and personality changes. Hetriva 4.6mg Patch increases the amount of acetylcholine and helps brain cells to communicate. It can, therefore, improve some of the symptoms such as memory, awareness, and the ability to carry out daily functions for a time. However, it is not a cure.You should use the patches exactly as they have been prescribed and only use one at a time. Choose a different place on your body to wear the patch each time you put on a new one. It can take several weeks for your symptoms to improve; so keep applying the patches even if you do not think they are working.
Side effects of Hetriva Patch The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Hetriva Depression Stomach pain Urinary tract infection Muscle weakness Tiredness Sleep disorder
How to use Hetriva Patch Use this medicine in dose and duration as advised by your doctor. Check the label before use. Make sure the skin is clean and dry. Remove the protective liner of the patch. Do not touch the sticky side. With sticky side down, place the patch evenly onto the skin.
How Hetriva Patch works Memory loss in Alzheimer�s disease occurs due to disturbances of signal transmission in the brain. Hetriva 4.6mg Patch is a cholinesterase inhibitor. It works by increasing the levels of a chemical messenger (acetylcholine) involved in transmmission of nerve signals. This improves memory and thinking.
No interaction has been found or established.
Hetriva 4.6mg Patch is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Hetriva 4.6mg Patch is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
No interaction found/established
No interaction found/established
No interaction found/established
If you forget a dose of Hetriva 4.6mg Patch , simply continue with your regular schedule and do not take a double dose.
S.no: 80-84, Melange towers, PatrikaNagar,Madhapur,Hyderabad. Telangana-500081.
Stahl SM, editor. Rivastigmine. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 603-607
Katzung BG. Special Aspects of Geriatric Pharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 1041
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1229
Rivastigmine. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2008 (22 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (22 Mar. 2019)
Rivastigmine transdermal system (20 Feb. 2024)
Rivastigmine (19 Mar. 2025)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.